| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
1
Biochemistry Section, Pathcentre, QE II Medical Centre, Nedlands, Western Australia 6009, Australia.
2
University Department of Medicine, University of Western
Australia, and
3
Department of Gastroenterology, Fremantle
Hospital, Fremantle, Western Australia 6160, Australia.
4
Busselton Population Medical Research Foundation,
Nedlands, Western Australia 6009, Australia.
5
Department of Public Health, University of Western
Australia, Nedlands, Western Australia 6907, Australia.
6
Queensland Institute of Medical Research, Brisbane,
Queensland 4029, Australia.
a Author for correspondence. Fax 61-8-9346-3882; e-mail ric.rossi{at}health.wa.gov.au
Background: Women who inherit heterozygosity for the C282Y mutation of the HFE gene may have increased serum iron indices and hemoglobin and are less likely to develop iron deficiency compared with women with the wild-type genotype.
Methods: We performed a cross-sectional analysis of 497 women 20–44 years of age and 830 women >51 years of age drawn from the Busselton (Australia) population study to assess the effects of the HFE genotype on serum iron and hematology indices.
Results: Heterozygosity for the C282Y mutation occurred in 13.8% of the study population, comprising 11.8% C282Y wild-type heterozygotes and 2.0% C282Y/H63D compound heterozygotes. In the younger age group, C282Y wild-type women did not have significantly increased serum iron, transferrin saturation, or hemoglobin values, and were not protected from developing iron deficiency, compared with women of the same age with the wild-type genotype. Young compound heterozygous women had higher means for serum iron (25.0 vs 16.9 µmol/L; P <0.001), transferrin saturation (42.0% vs 25.6%; P <0.05), hemoglobin (139.4 vs 132.3 g/L; P <0.05), and corpuscular volume (91.1 vs 87.7 fL; P <0.05), and a higher median ferritin (53 vs 44 µg/L; P <0.05) compared with the wild-type genotype. Similar results were observed for compound heterozygotes in the >51 years age group.
Conclusions: Women with the compound heterozygous HFE genotype C282Y/H63D, but not the C282Y wild-type genotype, had increased values for serum iron and transferrin saturation, and the younger age group also had increased hemoglobin values. We conclude that the compound heterozygous genotype may have a beneficial effect in protecting women from iron deficiency.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  A. T. Chan, J. Ma, G. J. Tranah, E. L. Giovannucci, N. Rifai, D. J. Hunter, and C. S. Fuchs Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women J Natl Cancer Inst, June 15, 2005; 97(12): 917 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Brugnara Iron Deficiency and Erythropoiesis: New Diagnostic Approaches Clin. Chem., October 1, 2003; 49(10): 1573 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J Fleming, K. L Tucker, P. F Jacques, G. E Dallal, P. W. Wilson, and R. J Wood Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1375 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. McLaren, K.-T. Li, V. R. Gordeuk, V. Hasselblad, and G. D. McLaren Relationship between transferrin saturation and iron stores in the African American and US Caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey Blood, October 15, 2001; 98(8): 2345 - 2351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Koziol, N. J. Ho, V. J. Felitti, and E. Beutler Reference Centiles for Serum Ferritin and Percentage of Transferrin Saturation, with Application to Mutations of the HFE Gene Clin. Chem., October 1, 2001; 47(10): 1804 - 1810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Fleming, P. F Jacques, J. M Massaro, R. B D'Agostino Sr, P. W. Wilson, and R. J Wood Aspirin intake and the use of serum ferritin as a measure of iron status Am. J. Clinical Nutrition, August 1, 2001; 74(2): 219 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J Fleming, P. F Jacques, K. L Tucker, J. M Massaro, R. B D'Agostino Sr, P. W. Wilson, and R. J Wood Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores Am. J. Clinical Nutrition, March 1, 2001; 73(3): 638 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Rossi, M. K. Bulsara, J. K. Olynyk, D. J. Cullen, L. Summerville, and L. W. Powell Effect of Hemochromatosis Genotype and Lifestyle Factors on Iron and Red Cell Indices in a Community Population Clin. Chem., February 1, 2001; 47(2): 202 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Rossi, B. M. McQuillan, J. Hung, P. L. Thompson, C. Kuek, and J. P. Beilby Serum Ferritin and C282Y Mutation of the Hemochromatosis Gene as Predictors of Asymptomatic Carotid Atherosclerosis in a Community Population Stroke, December 1, 2000; 31(12): 3015 - 3020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Beutler, V. Felitti, T. Gelbart, and N. Ho The Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic Ann Intern Med, September 5, 2000; 133(5): 329 - 337. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
